Healthcare facilities operating Automated Impella Controller units must implement three critical actions immediately to address the FDA’s safety correction. First, verify all device serial numbers against the official FDA list to determine which units in your facility are affected by the identified hardware vulnerabilities. This verification step is essential for prioritizing resources and ensuring comprehensive facility coverage.
Second, contact Abiomed directly to schedule mandatory hardware updates for all affected controllers. These updates address the specific hardware issues that could interrupt hemodynamic support during cardiac procedures. Third, establish or maintain backup cardiac support systems to ensure continuity of care while hardware corrections are being implemented.
These practical measures protect both patients and clinical operations during the correction period. Healthcare providers should communicate transparently with their cardiac teams about device status and timeline for updates. Proactive management of this safety issue demonstrates institutional commitment to patient safety and device reliability. Read the full article on GMJ Newsroom.
Was this article helpful?
